1. Home
  2. CYBN vs BKKT Comparison

CYBN vs BKKT Comparison

Compare CYBN & BKKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYBN
  • BKKT
  • Stock Information
  • Founded
  • CYBN 2019
  • BKKT 2018
  • Country
  • CYBN Canada
  • BKKT United States
  • Employees
  • CYBN N/A
  • BKKT N/A
  • Industry
  • CYBN Pharmaceuticals and Biotechnology
  • BKKT Computer Software: Prepackaged Software
  • Sector
  • CYBN Health Care
  • BKKT Technology
  • Exchange
  • CYBN Nasdaq
  • BKKT Nasdaq
  • Market Cap
  • CYBN 178.7M
  • BKKT 156.2M
  • IPO Year
  • CYBN N/A
  • BKKT N/A
  • Fundamental
  • Price
  • CYBN $7.54
  • BKKT $9.27
  • Analyst Decision
  • CYBN Strong Buy
  • BKKT
  • Analyst Count
  • CYBN 4
  • BKKT 0
  • Target Price
  • CYBN $85.00
  • BKKT N/A
  • AVG Volume (30 Days)
  • CYBN 412.3K
  • BKKT 1.3M
  • Earning Date
  • CYBN 08-12-2025
  • BKKT 08-13-2025
  • Dividend Yield
  • CYBN N/A
  • BKKT N/A
  • EPS Growth
  • CYBN N/A
  • BKKT N/A
  • EPS
  • CYBN N/A
  • BKKT N/A
  • Revenue
  • CYBN N/A
  • BKKT $3,710,548,000.00
  • Revenue This Year
  • CYBN N/A
  • BKKT N/A
  • Revenue Next Year
  • CYBN N/A
  • BKKT N/A
  • P/E Ratio
  • CYBN N/A
  • BKKT N/A
  • Revenue Growth
  • CYBN N/A
  • BKKT 128.83
  • 52 Week Low
  • CYBN $4.81
  • BKKT $6.81
  • 52 Week High
  • CYBN $13.88
  • BKKT $37.21
  • Technical
  • Relative Strength Index (RSI)
  • CYBN 46.24
  • BKKT 33.73
  • Support Level
  • CYBN $7.26
  • BKKT $21.50
  • Resistance Level
  • CYBN $7.81
  • BKKT $25.40
  • Average True Range (ATR)
  • CYBN 0.45
  • BKKT 2.22
  • MACD
  • CYBN -0.04
  • BKKT -1.74
  • Stochastic Oscillator
  • CYBN 17.72
  • BKKT 2.21

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

About BKKT Bakkt Holdings Inc.

Bakkt Holdings Inc operates technology that connects the digital economy by offering a platform for crypto and redeeming loyalty points. Its institutional-grade technology platform provides a custody solution that caters to more experienced market participants to store crypto and provides consumers, businesses, and institutions with the ability to buy, sell, and store crypto in a simple, intuitive digital experience accessed via application programming interfaces (APIs) or embedded web experience and Loyalty offers a full spectrum of content that clients can make available to its customers when redeeming loyalty currencies. It generates revenue in the form of Subscription and service and Transaction revenue.

Share on Social Networks: